A lot of opportunities exist in the biotech world today. I don't think our newest board members would have bothered with Medizone if they thought the 510k situation was insurmountable or our new CEO wasn't committed to making things happen.....in our lifetimes.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.